Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-15-009912
Filing Date
2015-09-25
Accepted
2015-09-25 13:43:02
Documents
23

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 45106
2 filename2.htm EX-3 286606
3 filename3.htm EX-8 15135
4 filename4.htm EX-8 6258
5 filename5.htm EX-10 265816
6 filename6.htm EX-10 23738
7 filename7.htm EX-10 288708
8 filename8.htm EX-10 368019
9 filename9.htm EX-10 312902
10 filename10.htm EX-10 50984
11 GRAPHIC g164391.jpg GRAPHIC 46630
12 GRAPHIC g164392.jpg GRAPHIC 49934
13 GRAPHIC g164393.jpg GRAPHIC 47934
14 GRAPHIC g164394.jpg GRAPHIC 48781
15 GRAPHIC g164395.jpg GRAPHIC 49390
16 GRAPHIC g164396.jpg GRAPHIC 46566
17 GRAPHIC g164397.jpg GRAPHIC 49737
18 GRAPHIC g164398.jpg GRAPHIC 45816
19 GRAPHIC g1643911.jpg GRAPHIC 7016
20 GRAPHIC g16439211.jpg GRAPHIC 27131
21 GRAPHIC g16439212.jpg GRAPHIC 27152
22 GRAPHIC g16439213.jpg GRAPHIC 27028
23 GRAPHIC g16439229.jpg GRAPHIC 5442
  Complete submission text file 0000950123-15-009912.txt   2323754
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 693 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01130 | Film No.: 151124850
SIC: 2834 Pharmaceutical Preparations